Alignment System Cranial, Alignment Software Cranial, Cirq Alignment Software Cranial Biopsy, Cirq Alignment Software Cranial sEEG, Varioguide Alignment Software Cranial

The Alignment System Cranial is an image-guided surgical navigation system utilizing optical tracking technology to assist surgeons in accurately planning and executing trajectories for instruments during cranial stereotactic procedures. Indicated for intracranial biopsies and SEEG electrode placement, the system now incorporates a static AI/ML-based Convolutional Neural Network to aid in the optional pre-registration step of patient surface matching.

The Alignment System Cranial, along with its associated software components (Alignment Software Cranial, Cirq Alignment Software Cranial Biopsy, Cirq Alignment Software Cranial sEEG, and Varioguide Alignment Software Cranial), is an image-guided surgery system designed to support surgeons in planning and accurately achieving a trajectory for surgical instruments during cranial stereotactic procedures. Its specified indications include the biopsy of intracranial lesions and the placement of stereoelectroencephalography (SEEG) electrodes. The system employs optical tracking technology to monitor the position of instruments relative to the patient's anatomy, displaying this information on pre- or intraoperative images. This real-time positional data is then utilized by the Alignment Software Cranial to align either passive (e.g., Varioguide) or active (e.g., Surgical Base System 1.4, Cirq Arm System 2.0) positioning devices, which are articulated arms, to a pre-planned surgical trajectory. The system consists of an Image Guided Surgery (IGS) platform (comprising a computer unit, touch display, and infrared tracking camera), various hardware configurations tailored to the specific positioning device and indication, and a set of non-sterile, indication-specific instruments constructed from stainless steel alloys. A notable technological advancement is the introduction of an AI/Machine Learning (AI/ML) feature for pre-registration: a static, supervised Convolutional Neural Network (CNN) that provides guide points to aid in surface matching, though this step is optional. Performance testing confirmed the software's integrity (classified as a "major" level of concern), the AI/ML landmark detection's equivalent performance to conventional methods, usability for new biopsy and SEEG workflows, and system accuracy (Mean Positional Error ≤ 2 mm, Mean Angular Error ≤ 2°). Additionally, electrical safety, electromagnetic compatibility, and instrument integrity (including biocompatibility, cleaning/disinfection reprocessing, mechanical properties, and stability) were successfully validated. Clinical testing was not deemed necessary due to the established nature of optical tracking technology in image-guided surgery for these indications.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the performance of the AI/ML-based pre-registration algorithm compare to traditional manual or atlas-based pre-registration in terms of speed, accuracy, and robustness across diverse patient anatomies and image qualities?; What are the specific failure modes or limitations of the static AI/ML algorithm for landmark detection, and what safeguards or alternative workflows are recommended if it provides suboptimal guide points?; Can the system quantitatively assess and compensate for potential inaccuracies introduced by brain shift or patient movement during lengthy SEEG procedures, beyond initial registration and alignment?; How does the workflow efficiency and accuracy for SEEG electrode placement using the Cirq Alignment Software compare to established robotic or manual SEEG techniques, particularly regarding deep brain targets or complex trajectories?; What is the learning curve for surgeons to achieve proficiency with the various hardware configurations (e.g., Varioguide vs. Cirq Arm System) and effectively utilize the new AI/ML features for both biopsy and SEEG procedures?